supported by grants from the Department of Health of Heilongjiang Province, China (2006-228);the Educational Commission of Heilongjiang Province, China(11531096);the National Natural Science Foundation of China (31100819, 30970980);the Natural Science Foundation of Guangdong Province, China (S2011040002239);the China Postdoctoral Science Foundation (2010-0480805)
Objective Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to cognitive dysfunctions like Alzheimer's disease (AD). Although amyloid-β (Aβ) aggregation is a pathological hallma...